A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : m-AMSA

Search Conditions:
Search Keyword : m-AMSA
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: m-AMSA
Appearance Frequency: 151 time(s)
Long forms: 15

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
4'-(9-acridinylamino)methanesulfon-m-anisidide
(112 times)
Neoplasms
(46 times)
DFMO (3 times)
DSB (3 times)
MDR (3 times)
1974 An assessment of the immunosuppressive activity of the anti-tumour compound--4'-((9-acridinyl)amino)methanesulphon-m-anisidide (m-AMSA).
methanesulfon-m-anisidide
(24 times)
Neoplasms
(13 times)
ADM (2 times)
AML (1 time)
ANLL (1 time)
1981 Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin.
molecular interactions of the potent antitumor drug amsacrine
(2 times)
Biochemistry
(1 time)
SER (1 time)
1996 Intracellular molecular interactions of antitumor drug amsacrine (m-AMSA) as revealed by surface-enhanced Raman spectroscopy.
N-(4-(acridin-9-ylamino)-3-methoxyphenyl)methanesulfonamide
(2 times)
Neoplasms
(1 time)
DOX (1 time)
ER (1 time)
MDR (1 time)
1989 Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.
m-amsacrine
(1 time)
Public Health
(1 time)
MIC (1 time)
2009 Partial purification and characterization of Trichomonas vaginalis DNA topoisomerase II.
made resistant to amsacrine
(1 time)
Neoplasms
(1 time)
--- 1987 Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide
(1 time)
Biochemistry
(1 time)
--- 1984 Absence of a requirement for long-range DNA torsional strain in the production of protein-associated DNA strand breaks in isolated mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).
manner, and this activity was inhibited by 4'-(9-acridinylamino)-3'-methoxymethanesulfonanilide
(1 time)
Botany
(1 time)
ts (1 time)
2003 Molecular characterization of a nuclear topoisomerase II from Nicotiana tabacum that functionally complements a temperature-sensitive topoisomerase II yeast mutant.
mechanisms not yet elucidated
(1 time)
Neoplasms
(1 time)
ADR (1 time)
cis-DDP (1 time)
L-PAM (1 time)
1982 Effect of L-phenylalanine mustard, adriamycin, actinomycin D, and 4'-(9-acridinylamino)methanesulfon-m-anisidide on naturally occurring human spontaneous monocyte-mediated cytotoxicity.
10  Meta AMSA
(1 time)
Gynecology
(1 time)
--- 1982 Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
11  meta-amsacrine
(1 time)
Hematology
(1 time)
VBL (1 time)
2009 [Discrimination of anticancer agent action loci at G(2) and M phases by flow cytometry and confocal microscopic imaging].
12  microM amsacrine
(1 time)
Neoplasms
(1 time)
--- 1988 Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells.
13  mitochondrial enzyme was inhibited by amsacrine
(1 time)
Biochemistry
(1 time)
--- 1991 DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26.
14  more effectively than amsacrine
(1 time)
Antineoplastic Agents
(1 time)
CPT (1 time)
MDR (1 time)
topo (1 time)
2003 Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities.
15  myeloma were treated with Amsacrine
(1 time)
Neoplasms
(1 time)
--- 1989 Phase II trial of amsacrine in patients with multiple myeloma.